Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating respiratory viruses, today announced that all participants have completed their ...

Alvotech (NASDAQ: ALVO), a global biotech company specializing in the development and manufacture of biosimilar medicines for patients worldwide (“Alvotech”), and Dr. Reddy’s Laboratories Ltd., (BSE: ...

“This marks a major milestone in MEME Coins Inc.’s strategy to secure high-value digital assets as we build out our blockchain-based ecosystem,” said a CBDS company representative. “DOG tokens have ...

Royal Philips (NYSE: PHG, AEX: PHIA), today announced that the exchange ratio for the dividend for the year 2024 is 1 new common share for every 23.6353 existing common shares. This ratio was based on ...

ZUG, Switzerland, June 05, 2025 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (“Oculis” or the “Company”), today announced the results from its 2025 Annual General Meeting held on ...

UTRECHT, Pays-Bas et CAMBRIDGE, Massachusetts, 05 juin 2025 (GLOBE NEWSWIRE) -- Merus N.V. (Nasdaq : MRUS) (« Merus », la « Société », « nous » et « notre »), une société spécialisée dans l’oncologie ...

Dr. George Katibah, Chief Scientific Officer of CancerVax said, “We anticipate that our targeted nanoparticles will improve delivery of our Smart mRNAs to cancer cells while significantly reducing ...

Paris, le 5 juin 2025. Sanofi lance Action 2025, son plan mondial d’actionnariat salarié, qui sera ouvert le 10 juin 2025 à environ 70 000 salariés dans 55 pays. Ce plan, qui entre dans sa onzième ann ...

Paul Hudson Chief Executive Officer of Sanofi "The Board of Directors and I are particularly proud to see the growing participation of our employees in our global employee shareholder plan, a ...

Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage biopharmaceutical company committed to meeting the needs of patients with severe bacterial and fungal infections, announced today ...

Ro5 Inc. acquisition enhances artificial intelligence/machine learning drug discovery capabilities; Strategic addition strengthens Juvenescence’s AI-enabled therapeutics pipelin ...

Paris, France (5 June 2025) – EssilorLuxottica announces today it has signed an agreement for the acquisition of one of the largest optical companies in Malaysia operating over 90 stores under the ...